USP22 and neoplasm: Even when a higher number of 4T1 cells, 103 and 104, were orthotopically injected, USP22 deletion dramatically inhibited the development of syngeneic tumors (Fig. 1H & 1I), indicating that USP22 is critical for in vivo tumor initiation.